Newsletters | ARK Investment Management

#504 Mar 30, 2026

#504: Elon Musk Unveils Terafab, A Chip Fab That Will Impact SpaceX, xAI, And Tesla, & More

In this issue:

#503 Mar 23, 2026

#503: Nvidia Has A Plan For Powering AI Agents, & More

In this issue:

#502 Mar 16, 2026

#502: What Will Prasad’s Departure From The FDA Mean For Drug Development?, & More

In this issue:

#501 Mar 09, 2026

#501: Robinhood Is Creating A Financial SuperApp, & More

In this issue:

#500 Mar 03, 2026

#500: Yes, AI Is Enabling Block To Cut Its Workforce By 40%, But..., & More

In this issue:

#499 Feb 24, 2026

#499: Grail's NHS Trial Failed To Meet Its Primary Endpoint, & More

In this issue:

#498 Feb 17, 2026

#498: SpaceX Pivots To The Moon, & More

In this issue:

#504: Elon Musk Unveils Terafab, A Chip Fab That Will Impact SpaceX, xAI, And Tesla, & More

#503: Nvidia Has A Plan For Powering AI Agents, & More

#502: What Will Prasad’s Departure From The FDA Mean For Drug Development?, & More

#501: Robinhood Is Creating A Financial SuperApp, & More

#500: Yes, AI Is Enabling Block To Cut Its Workforce By 40%, But..., & More

#499: Grail's NHS Trial Failed To Meet Its Primary Endpoint, & More

#498: SpaceX Pivots To The Moon, & More

Explore ARK’s Newsletter

#504: Elon Musk Unveils Terafab, A Chip Fab That Will Impact SpaceX, xAI, And Tesla, & More

#503: Nvidia Has A Plan For Powering AI Agents, & More

#502: What Will Prasad’s Departure From The FDA Mean For Drug Development?, & More

#501: Robinhood Is Creating A Financial SuperApp, & More

#500: Yes, AI Is Enabling Block To Cut Its Workforce By 40%, But..., & More

#499: Grail's NHS Trial Failed To Meet Its Primary Endpoint, & More

#498: SpaceX Pivots To The Moon, & More